SwabSeq still has steps to take before it can make their agnostic test available to the public. In addition to developing the new technology, it also must obtain regulatory approval from the Food and ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc. today announced it has been awarded a contract from the Division of Research, Innovation, and Ventures (DRIVe), under the Biomedical Advanced ...
FOSTER CITY, Calif., May 30, 2025 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular residual disease (MRD) monitoring and early cancer detection through a proprietary ...
UCLA Health is joining a new effort to increase the ability to quickly respond to emerging pathogens by creating the capability to detect all existing and new respiratory RNA viruses in a single test.
While we have long forgotten the Mendelian models and single-gene testing panels in the field of oncology, we have not yet reached agnostic testing or population screening for cancer—although we are ...
Chemo-praidict eBC: A deep learning solution for predicting pathological complete response on biopsies of breast cancer patients treated with neoadjuvant chemotherapy. Big data analysis of outcomes in ...
HERNDON, Va.--(BUSINESS WIRE)--Fine Point Technologies today announced the release of Speed Master, a software module that enables highly efficient and scalable, vendor agnostic bulk speed testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback